ArticleInfection and drug resistance2026
Clinical Characteristics of
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Complete Blood Count-Derived Inflammatory Markers in Pediatric Lower Respiratory Tract Infection: A Narrative Review.Pathogens (Basel, Switzerland) · 2026Review
- East Asia as a sentinel: risk-stratified corticosteroid therapy for paediatric macrolide-resistantEuropean respiratory review : an official journal of the European Respiratory Society · 2026Review
- Serum HMGB3 and PCSK9 Levels as Predictors of Early Treatment Response in PediatricInternational journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To analyse the clinical features of Patients and Methods: The clinical data of children with MPP who were treated in our hospital from January 2021 to December 2022 were collected and retrospectively analysed. 83 cases were assigned to the severe group (SMPP group) and 152 cases were assigned to the general group (MPP group). The epidemiology, clinical characteristics and related influencing factors of SMPP were analysed. Results: Compared with the MPP group, the SMPP group were older, had a longer fever time, had more imaging manifestations of large patchy consolidation and experienced a longer hospital stay. The peripheral blood white blood cell (WBC) count, C-reactive protein (CRP), serum IgA, serum IgG, serum IgM, lactate dehydrogenase (LDH) and ferritin (SF) in the SMPP group were significantly higher than those in the MPP group ( Conclusion: All patients with MMP had a fever and a cough, and patients with SMPP had a high fever. Chest imaging examination of patients with SMPP showed extensive consolidation shadows in the lungs, and laboratory examinations showed significant increases in WBCs, CRP, LDH and SF. The fever time, CRP, LDH and imaging showed large patchy consolidation shadows are related to the severity of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.